STAT
NOVEMBER 19, 2024
patent expires in 2028. Although more pharmaceutical companies are tailoring their business models to focus on low-income countries, overall industry efforts remain limited and patient access continues to suffer as a result , STAT writes, citing a new analysis.
Express Pharma
JUNE 30, 2025
The fact that this single city accounts for roughly one-third of India’s pharmaceutical output and a similar proportion of global vaccine production underscores its role in global health. This prominence isn’t accidental. It’s the outcome of a long-term strategy spearheaded by government policies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
APRIL 10, 2025
billion in 2028, growing at a compound annual growth rate (CAGR) of 14.16 The company is focused on increasing adoption across hospitals and clinics while securing regulatory approvals in additional global markets. Needle-free injection technology is steadily gaining traction in the traditional injection market.
STAT
JULY 9, 2025
Details on pharmaceutical tariffs “will come at the end of the month,” U.S. The planned tariffs would deal a long-awaited blow to pharmaceutical companies, many of which have pushed back and warned that the levies could drive up costs, deter investments in the U.S., billion in 2021. Merck
Pharmaceutical Technology
JUNE 10, 2025
Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028, RFK Jr wrote. He noted that these conflicts of interest continue to the current day, with ACIP members receiving substantial funding from pharmaceutical companies.
European Pharmaceutical Review
OCTOBER 24, 2023
Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2028, according to a report by Arizton. billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent up to 2028. percent in 2022.
STAT
JULY 29, 2024
Thomas Schinecker, chief executive of the pharmaceutical company, said its first obesity drugs would come to market “significantly faster than people are expecting,” potentially by 2028. The treatments, acquired in a $3.1 reduction in weight compared with a placebo after four weeks.
Expert insights. Personalized for you.
Let's personalize your content